Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis
- Fatemeh Momen-Heravi†1,
- Banishree Saha†1,
- Karen Kodys1,
- Donna Catalano1,
- Abhishek Satishchandran1 and
- Gyongyi Szabo1Email author
© Momen-Heravi et al. 2015
Received: 1 May 2015
Accepted: 29 July 2015
Published: 12 August 2015
It has been well documented that alcohol and its metabolites induce injury and inflammation in the liver. However, there is no potential biomarker to monitor the extent of liver injury in alcoholic hepatitis patients. MicroRNAs (miRNAs) are a class of non-coding RNAs that are involved in various physiologic and pathologic processes. In the circulation, a great proportion of miRNAs is associated with extracellular vesicles (EVs)/exosomes. Here, we hypothesized that the exosome-associated miRNAs can be used as potential biomarkers in alcoholic hepatitis (AH).
Exosomes were isolated from sera of alcohol-fed mice or pair-fed mice, and plasma of alcoholic hepatitis patients or healthy controls by ExoQuick. The exosomes were characterized by transmission electron microscopy and Western blot and enumerated with a Nanoparticle Tracking Analysis system. Firefly™ microRNA Assay was performed on miRNA extracted from mice sera. TaqMan microRNA assay was used to identify differentially expressed miRNAs in plasma of cohort of patients with AH versus controls followed by construction of receiver operating characteristic (ROC) curves to determine the sensitivity and specificity of the candidates.
The total number of circulating EVs was significantly increased in mice after alcohol feeding. Those EVs mainly consisted of exosomes, the smaller size vesicle subpopulation of EVs. By performing microarray screening on exosomes, we found nine inflammatory miRNAs which were deregulated in sera of chronic alcohol-fed mice compared to controls including upregulated miRNAs: miRNA-192, miRNA-122, miRNA-30a, miRNA-744, miRNA-1246, miRNA 30b and miRNA-130a. The ROC analyses indicated excellent diagnostic value of miRNA-192, miRNA-122, and miRNA-30a to identify alcohol-induced liver injury. We further validated findings from our animal model in human samples. Consistent with the animal model, total number of EVs, mostly exosomes, was significantly increased in human subjects with AH. Both miRNA-192 and miRNA-30a were significantly increased in the circulation of subjects with AH. miRNA-192 showed promising value for the diagnosis of AH.
Elevated level of EVs/exosomes and exosome-associated miRNA signature could serve as potential diagnostic markers for AH. In addition to the biomarker diagnostic capabilities, these findings may facilitate development of novel strategies for diagnostics, monitoring, and therapeutics of AH.
KeywordsAcute alcoholic hepatitis Alcohol Liver injury Extracellular vesicles Exosomes Microvesicles Biomarker Liquid biopsy Human miRNA
Alcoholic hepatitis (AH) is an acute hepatic inflammation accompanied with substantial morbidity and mortality and increasing health problems across the world. AH is a result of the complex interactions between ethanol metabolism, inflammation, and innate immunity on the liver . Currently the enzymatic activity of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in blood are the most commonly used indicators for detection of liver damage; however, increased serum ALT- and AST are not specific for the type of liver disease, the extent of liver damage or the absence or presence of liver inflammation. In addition, ALT/AST increase is not specific to AH and occurs in many other liver disorders [2, 3]. Moreover, these two diagnostic markers do not always correlate well with the disease stage and extent of hepatocellular damage or liver fibrosis .
MicroRNAs (miRNAs) are small (17–25 nucleotide long) non-coding RNAs that regulate gene expression post-transcriptionally [4, 5]. miRNAs play important roles in different pathogenesis pathways and can be deregulated in different diseases. A growing body of evidence shows that miRNAs can act as novel biomarkers for diagnosis and therapeutic monitoring of various diseases such as cancers, neurodegenerative disorders, heart disease, and infection [5–8]. miRNAs play a substantial role in the regulatory gene expression process and it is estimated that about one-third of the human genome transcriptome being regulated by actions of miRNAs . miRNAs influence gene regulation of essential biological pathways such as cellular development, proliferation, apoptosis, and cellular signaling [5, 10]. From its intracellular origin, miRNA can be secreted extracellularly bound to AGO2 , or secreted in cell-derived extracellular vesicles/exosomes and serve as personalized signatures reflecting the disease status or perform cell-to-cell communication .
Differential expression signatures of miRNAs associated with different diseases have been evaluated mostly in whole plasma and serum [12, 13]. However, it can be difficult to interpret the result of disease-specific miRNA biomarkers in healthy and diseased patients due to genetic material instability stemming from RNases, sample variation, normalization, and nonspecific activated pathways in various diseases . With the introduction of EVs as an enriched source of miRNAs, new horizons opened in biomarker discovery based on EVs . EVs are a mixed population of heterogeneous membranous vesicles shedding from cells in both physiological and pathological states. Their sizes range from 50 nm in diameter and up to 1,000 nm . Exosomes are the smallest subpopulation of EVs originating from multivesicular bodies and can be isolated from different biofluids using standardized protocols. Exosomes can act as stable reservoirs of biomarkers in different diseases by containing genetic materials that reflect the disease stage .
A great proportion of circulating miRNA is associated with exosomes. Exosome associated miRNA is reported to be more stable and resistant to RNase enzymatic activity compared to non-exosome associated miRNAs [17, 18]. Although there is some evidence indicating deregulation of miRNAs in different liver diseases [19, 20], there is no study regarding the biomarker value of exosome-associated miRNAs in AH. The aim of the present study was to assess the utility of exosome-associated miRNAs as potential biomarkers for AH. In the present study, we demonstrate that miRNAs in circulation are largely encapsulated in exosomes and carry a specific signature after alcohol induced liver injury in chronic alcohol fed mice and patients with AH. We used chronic alcohol feeding in a mouse model and found a specific signature of miRNA associated with liver injury. Next, we validated our results in a cohort of human subjects with AH. Our results indicate that exosomes transport alcohol induced liver injury-specific molecular information in the circulation.
Confirmed cases of alcoholic hepatitis (n = 14) and healthy individuals (n = 10) were enrolled in the study. The diagnosis of alcoholic hepatitis was established by expert clinicians based on medical history, physical examination and laboratory data according to the guidelines of the American College of Gastroenterology . In cases of uncertain diagnosis, liver biopsy was obtained. Patients were included from different stages of alcoholic hepatitis. Healthy individuals were defined as being free of any systemic and non-systemic diseases based on patients’ history and routine laboratory findings identified by primary care physician. These individuals provided history of “only social” alcohol consumption. Both controls and patients were enrolled consecutively to study to avoid selection bias. The study protocol was approved by Institutional Review Board for the Protection of Human Subjects in research at the University of Massachusetts Medical School (Worcester, MA, USA). Written informed consents were obtained from all subjects.
6 to 8-week-old female C57BL/6 mice were purchased from Jackson Laboratory. The animal study protocol was approved and conducted according to the regulations of the Institutional Animal Care and Use Committee (IACUC) of the University of Massachusetts Medical School (Worcester, MA, USA). In the alcohol experimental group (n = 12), mice received 5% (v/v) ethanol (36% ethanol-derived calories) containing Lieber–DeCarli diet (EtOH) for 4 weeks. The matched pair-fed animals received (n = 12) an isocaloric alcohol-free diet (pair-fed) to ensure equal nutrient and calorie intake between groups. Mice were euthanized at the end of experimental time course and serum was separated from the whole blood and the livers were collected. Serum ALT was measured using a kinetic method (D-Tek LLC).
For histopathological analysis, sections of formalin-fixed livers were stained with hematoxylin–eosin to study for steatosis, necrosis and inflammation. Flowcytometry was performed to study the immune cell population in the liver of the pair fed and ethanol fed mice as previously described .
For exosome isolation from sera of mice and plasma of human subjects, exosomes were isolated from 150 µl of sera or plasma following the previously established protocol . Briefly, the serum or plasma were centrifuged at 1,500×g for 5 min to remove cells and 10,000×g for 20 min to remove residual cellular debris. Samples were serially filtered through 0.8, 0.44 μm (Millipore, Billerica, MA, USA). The filtered supernatant was used to precipitate exosomes with Exoquick-TC™ (according to the manufacturer’s guidelines). Exosome pellet was re-suspended in PBS. For isolating smaller subpopulation of exosomes (diameter <200 nm) we added an additional step before re-suspension in PBS and filtered the samples with 0.2 µm filters.
Nanoparticle Tracking Analysis (NTA)
The concentration and size range of circulating EVs in human subjects and mice were identified by a NanoSight NS300 system (NanoSight, Amesbury, UK) supplied with a fast video capture and Nanoparticle Tracking Analysis (NTA) software. Before performing the experiments, the instrument was calibrated with 100 nm polystyrene beads (Thermo Scientific, Fremont, CA, USA). The samples were captured for 60 s at room temperature. NTA software processed the video captures and measured the concentration of the particles (particles/ml) and size distribution (in nanometer). Each specimen was measured three times.
Isolated EVs from plasma and serum were re-suspended in PBS and placed on a formvar-coated copper grid and then allowed to settle for 45 min. Sequential PBS washing of the grid was done by positioning droplets of PBS on the top and applying absorbing paper in between. The samples were fixed by positioning the grid on the top of 2% paraformaldehyde placed on the parafilm for 15 min. After fixation and three washing steps, samples were contrasted by adding drops of 2% uranyl acetate for 15 min. A drop of 0.13% methyl cellulose and 0.4% uranyl acetate was placed on the parafilm grid was incubated at the top for 10 min. The grid was visualized by a Philips CM10 transmission electron microscope and images were recorded using a Gatan CCD digital camera.
After isolating exosomes from mice sera, presence of CD63 and GRP78 were determined with western blot, using our laboratory’s established protocol. Briefly, exosomes were lysed in RIPA buffer and run on a 15% polyacrylamide gel. Proteins were transferred to nitrocellulose membrane overnight then blocked for 3 h in blocking buffer (1× TBST with 5% w/v nonfat dry milk). Primary antibody against CD63 and GRP78 (Abcam, Cambridge, MA, USA) was used overnight at 4°C at 1:2,000 dilution in the blocking buffer. For detection, secondary goat anti-mouse HRP-linked antibody (Santa Cruz Biotechnology, Dallas, TX, USA) was used for 1 h at a dilution rate of 1:5,000 in blocking. The immunoreactive bands were visualized by a Clarity™ Western ECL substrate kit (BioRad) according to the manufacturer’s protocol and LAS-4000IR Ver.2.02 (Fujifilm, Valhalla, NY, USA). Mouse primary hepatocytes were used as negative control.
Isolated EVs from 150 μl of mice sera and patients’ plasma were lysed in 500 and 1,000 µl of QIAzol Lysis reagent, respectively. Total RNA was extracted using Direct-zol™ RNA MiniPrep isolation kit (Zymo Research Corp, Irvine, CA, USA). The standard manufacturer’s protocol was followed, and extracted RNA was eluted with 25 μl of RNase-free water. The RNA was quantified using and NanoDrop 1000 and the quality of RNA was assessed by 260/280 and 260/230 ratios.
In addition, the Firefly miRNA multiplex assay (Firefly™ bioworks, Cambridge, MA, USA) was used to profile EV-associated miRNA isolated from mice sera for a targeted list of 68 miRNAs. Total RNA (12 μl) was assayed by the Firefly standard protocol and analyzed with a Millipore Guava 8HT flow cytometer.
Data processing, analysis, and visualizations were performed using Firefly™ Analysis Workbench. The software was used to compare data quality with historical values, perform image processing, normalization, and transformation. Raw probe intensities were analyzed using Wilcoxon’s signed rank test. Signal intensities were transformed to log ratio for each probe on the alcohol group array to the counter parting probe pair on the control array. miRNA-15b was used for normalizing array data. Signal log ratio was computed by using a t test. After generating a list of differentially expressed miRNAs, down-stream analysis was performed. The identified miRNA were clustered in by K mean clustering and heat-map generated. The targets of miRNA-192 and miRNA-30a target were visualized using Cytoscape V2.7. miRDB, miRanda, and mirSVR databases were used for miRNAs target predictions.
We used TaqMan® miRNA Assays (Applied Biosystems, Catalog number: 4366597) for confirmation of microarray and evaluating the expression level of miRNA-122 (Applied Biosystems, Catalog number: A25576), miRNA-30a (Applied Biosystems, Catalog number: 4427975) and miRNA-192 (Applied Biosystems, Catalog number: A25576). Reverse transcription was performed using a TaqMan stem loop primer, TaqMan primers, 10 ng RNA, and miRNA reverse transcription kit in an Eppendorf Realplex Mastercycler (Eppendorf, Westbury, NY). The cycle was as follows: 30 min, 16°C; 30 min, 42°C; 5 min 85°C. The cDNA was mixed with TaqMan ® Universal PCR Master and quantitative real-time PCR was performed using a Bio-Rad CFX96 iCycler device. Synthetic C. elegans-miRNA-39 was spiked as external control during the total RNA isolation from human plasma samples. Consistent with the array findings, miRNA-15b was used for normalization of mice sera in confirmatory qPCR analysis. The amplification efficiency of qPCR was verified in our lab and it was very close to 100%. Samples were processed in duplicate and the relative expression level of specific miRNA calculated by 2−ΔΔCt method. NormFinder was used to identify the suitable endogenous normalizer .
Data are expressed as mean ± standard error (SE). For pair-wise comparisons, non-parametric Mann–Whitney test or parametric t-test were used based on underlying distribution. The ability to discriminate between the alcohol fed mice/alcoholic hepatitis patients and control groups was evaluated by the receiver operating characteristic curve, and the area under the curve (AUC) was calculated as a measure of test accuracy. For group-wise comparison, Kruskal–Wallis non parametric test or ANOVA parametric test were used and a p ≤ 0.05 was considered as statistically significant. Correlation of ALT with exosome numbers was identified by Spearman correlation test. For statistical analysis and heat map data visualization, GraphPad Prism v.4.03 (GraphPad Software Inc.) and Firefly™ Analysis Workbench software were used, respectively.
Total number of EVs is increased in alcohol-fed mice compared to the pair-fed mice
Correlation of ALT with exosome number
Introducing endogenous control normalizer in EVs isolated from mice sera
Next, liver miRNA microarray was performed on exosome-associated miRNA, using The Firefly™ microRNA Assay which includes miRNA signatures of 68 miRNAs associated with liver inflammatory pathways. First to ensure reproducibility and reliability, spiked positive control values were compared with historical value identified for the same amount of miRNAs. The spiked positive controls showed excellent correlation with historical values (p = 0.98) (Fig. 2c). This was a quality control step to evaluate the ability of the assay to distinguish different value of spiked positive control. Our results indicated that assay readouts were sensitive to the amount of miRNA and increase linearly when the amount of spiked in control increased. Of the 68 miRNAs indicated in the inflammatory panel, 63 miRNAs were detectable in our samples (Fig. 2d).
Stability values of different miRNAs based on NormFinder
Norm Finder ranking
Best combination of two genes
miRNA-20a and miRNA-15b
EVs isolated from ethanol-fed mice
EVs isolated from pair-fed mice
Differential miRNA signature of alcohol-fed mice versus control mice
Differential miRNA signature of extracellular-vesicles derived from sera of chronic alcohol-fed mice compared to the pair-fed mice
Increased miRNAs in alcohol-fed mice EVs vs paired-fed mice EVs
Decreased miRNAs in alcohol-fed mice EVs vs paired-fed mice EVs
miRNA-192, miRNA-122 and miRNA-30a accurately discriminate the alcohol-fed and control mice
ROC curve analysis indicating diagnostic value of each miRNA
AUC (area under the curve)
EVs from alcohol-fed mice vs paired-fed mice
P < 0.001
P < 0.001
P < 0.05
EVs from alcoholic hepatitis patients vs control individuals
p < 0.001
P = 0.56
Increased number of EVs in plasma of alcoholic hepatitis patients and characteristic miRNA profile of EVs
Extracellular vesicles, including microvesicles, exosomes and apoptotic bodies are released from almost all cell types into the microenvironment, and involved in physiological function and the pathology of different diseases . In this study, we found a significantly increased number of circulating EVs in sera of alcohol-fed mice compared to pair-fed mice. Similarly, we observed a significantly increased number of EVs in plasma of AH patients, compared to healthy controls. Interestingly, the vesicles in both animal model and human subjects were mostly in the size range of exosomes; the smaller subpopulation of vesicles. Although there are a few reports that address the roles of EVs in various liver diseases [27, 29–31], this is the first report regarding increased numbers of EVs in alcoholic hepatitis patients.
We found a strong linear correlation between exosome numbers and ALT levels, indicating that the exosomes machinery is affected and an increase in exosome numbers mirrors the hepatocellular damage induced by ethanol. Exosomes originate specifically from secretory multivesicular endosome bodies (MVBs). It has been shown that exosome biogenesis can be ESCRT-complex dependent or sphingomyelinase dependent. Tetraspanins, which are highly enriched in the MVBs, have often been associated with exosomes; smaller sub-fraction of EVs [32, 33]. In this study we observed an increased number of exosomes in the plasma of patients with alcoholic hepatitis and sera of mice after chronic alcohol feeding, which indicate the activation of exosome biogenesis pathways. The fact that we did not observe a considerable amount of microvesicles in models may indicate that the ethanol exposure induces cell stress below the threshold stress for inducing cell death . From the evolutionary biology point of view, increased amount of exosomes shedding after alcohol assault may indicate evolutionary plasticity of the cells for limiting the stressor constrain.
While the mechanism of the EVs biogenesis varies in different subpopulations, genetic materials were detected in all type of vesicles . Analysis of genetic material secreted within different subpopulation of EVs in circulation represents a unique opportunity for diagnosis and therapeutic monitoring of alcoholic hepatitis. Recent evidence suggests that circulating miRNAs can exist in two distinct forms: (1) as free floating EVs where they form a complex with Argonaute 2, the RNA induced silencing complex (RISC), or high density lipoproteins and (2) as packaged within the EVs/exosomes [36, 37]. We found that total RNA is more abundant in the exosome fraction compared to the non-exosome fraction. Exosome-based diagnosis confers several advantages for biomarker discovery compared to conventional strategies involving whole blood analysis. First, exosomes contain RNA, lipids, and proteins that are reflective of the status of parental cells and disease-specific protein or RNA, which are often detected in exosomes [35–37]. Second, the contents inside exosomes are protected by a lipid bilayer of exosomes, which leads to better stability of bio-macromolecules. Third, exosomes are very stable and can be stored for extended period of time. Fourth, exosome-based analysis reduces the complexity of biofluids thereby aiding in the more specific and more sensitive detection of low abundance bio-macromolecules [15, 38, 39]. Although different exosome isolation methods may yield varying results, using a validated established protocol for isolation demonstrates great reproducibility. We used a combination of serial filtration and ExoQuick for isolation of exosomes which has shown reproducibility and efficiency for quantitative studies .
We found nine deregulated inflammatory miRNAs in exosomes of alcohol-fed mice. Particularly, miRNA-122, miRNA-30a, and miRNA-192 showed the most substantial increases and revealed an excellent diagnostic value for differentiating alcohol-fed mice versus pair-fed mice. Importantly, of these miRNAs in the cohort of patients with alcoholic hepatitis, we found a significantly elevated level of miRNA-30a and miRNA-192 in the EV-fraction of plasma. This observation in human AH validated our findings in the animal model and indicates that the chronic Lieber DeCarli ethanol feeding model partially presents similar features of human AH. We found elevated levels of miRNA-122 in the circulation in the Lieber–DeCarli dietary mouse model. In contrast, we did not observe statistically significant elevation in miRNA-122 in exosomes isolated from sera of patients with alcoholic hepatitis, which may indicate the difference of the Lieber DeCarli alcohol model with alcoholic hepatitis in patients. This result might be attributed to the patients’ heterogeneity in terms of being in different stages of alcoholic hepatitis or having different kinetics of miRNA-122 in alcohol-induced liver injury.
miRNA-192 showed consistently elevated levels in both alcohol-fed mice samples and in patient- derived alcoholic hepatitis samples. miRNA-192 is the second most abundant miRNA in the human liver and considered as one of the liver specific miRNA constituting around 16.9% of the miRNome in normal liver tissue . In spite of the high abundance in the liver, its regulation in the liver is tightly controlled and was not changed in hepatocellular carcinoma and viral hepatitis . In a study done by our group , we showed differential distribution of miRNAs in exosomes and exosome-depleted serum fraction in different types of liver injury. In particular, in alcoholic hepatitis and in inflammatory liver injury, serum/plasma miRNA-122 and miRNA-155 were predominantly associated with the exosome-rich fraction.
We showed that miRNA-192 levels can be used to differentiate plasma from alcoholic hepatitis patients and plasma from controls. Importantly, our results were validated on plasma samples from several individuals. Interactome analysis of miRNA-192 revealed activation of Smad signaling and ZEB proteins, which are related to alcoholic hepatitis pathobiology through regulation of TGFβ/Smad signaling . Another target of miRNA-192 that showed overlap with known pathways of alcoholic hepatitis is Jak2/Arhgef1 signaling pathway, which is correlated with severity of liver disease .
The finding of elevated levels of miRNAs species in exosomes after alcohol administration from other tissues such as miRNA-30a, which is highly expressed in heart cells , may further demonstrate the effect of alcohol on multiple organs and cell types despite the majority of pathological damage being reported as confined to the liver. Indeed, chronic alcohol administration is associated with direct cardiomyopathy and anemia-induced cardiomyopathy, both in humans and animal models [46, 47]. The diverse origin of exosome-associated miRNAs also suggests that using circulating miRNA as a specific window into the physiopathological condition of the whole effects of alcohol, perhaps in concert with certain other markers profile, will be a powerful approach for diagnosis. However, more data regarding specificity of miRNA-192 and miRNA-30a for alcoholic hepatitis compared to the other types of liver disease, and side by side comparison of those miRNA markers with other markers of liver injury such as ALT should be gathered in future studies. Although we found significant discriminatory ability of exosomal miRNA-192 for alcoholic hepatitis, our study is in the discovery phase and has limited sample size. Further investigations are warranted to confirm our findings in larger cohorts of patients and comparing miR-192 with established scores such as MELD and Maddrey scores.
In this study we showed that the total number of circulating extracellular vesicles is significantly increased in alcohol-fed mice and human subjects with alcoholic hepatitis. Those EVs were in the range of smaller sub-population of EVs, called exosomes. Comparing the miRNA signature of exosomes from alcohol-fed mice with pair-fed mice showed deregulation of nine inflammatory miRNAs including miRNA-122, miRNA-192 and miRNA-30a. Of those, three miRNA were significantly up-regulated in alcohol-fed mice compared to pair-fed mice and had valuable diagnostic values. Consistently, miRNA-30a and miRNA-192 were increased significantly in exosomes isolated from plasma of alcoholic hepatitis patients.
Conceived and designed the experiments: FMH, BS, GS; Performed the experiments: FMH, BS KK, DC, AS; Analyzed and interpreted the data: FMH, BS, GS; Contributed reagents/materials/analysis tools: GS; Wrote the paper: FMH and GS. All authors read and approved the final manuscript.
This study was supported by Grants: AA021907, AA021893, and AA011576 to GS.
Compliance with ethical guidelines
Competing interests The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Orman ES, Odena G, Bataller R (2013) Alcoholic liver disease: pathogenesis, management, and novel targets for therapy. J Gastroenterol Hepatol 28(Suppl 1):77–84PubMed CentralPubMedView ArticleGoogle Scholar
- Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S (2008) The current state of serum biomarkers of hepatotoxicity. Toxicology 245:194–205PubMedView ArticleGoogle Scholar
- Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC (2008) Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 47:1363–1370PubMedView ArticleGoogle Scholar
- Iorio MV, Croce CM (2009) MicroRNAs in cancer. J Clin Oncol 27:5848–5856PubMed CentralPubMedView ArticleGoogle Scholar
- Farazi TA, Spitzer JI, Morozov P, Tuschl T (2011) miRNAs in human cancer. J Pathol 223:102–115PubMed CentralPubMedView ArticleGoogle Scholar
- Momen-Heravi F, Trachtenberg AJ, Kuo WP, Cheng YS (2014) Genomewide study of salivary microRNAs for detection of oral cancer. J Dent Res 93:86S–93SPubMed CentralPubMedView ArticleGoogle Scholar
- Akat KM, Moore-McGriff D, Morozov P, Brown M, Gogakos T, Correa Da Rosa J et al (2014) Comparative RNA-sequencing analysis of myocardial and circulating small RNAs in human heart failure and their utility as biomarkers. Proc Natl Acad Sci USA 111:11151–11156PubMed CentralPubMedView ArticleGoogle Scholar
- Bekris LM, Leverenz JB (2015) The biomarker and therapeutic potential of miRNA in Alzheimer's disease. Neurodegener Dis Manag 5:61–74PubMedView ArticleGoogle Scholar
- How CK, Hou SK, Shih HC, Huang MS, Chiou SH, Lee CH et al (2015) Expression profile of microRNAs in gram-negative bacterial sepsis. Shock 43:121–127PubMedView ArticleGoogle Scholar
- He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5:522–531PubMedView ArticleGoogle Scholar
- Gibbings D, Mostowy S, Jay F, Schwab Y, Cossart P, Voinnet O (2012) Selective autophagy degrades DICER and AGO2 and regulates miRNA activity. Nat Cell Biol 14:1314–1321PubMed CentralPubMedView ArticleGoogle Scholar
- Povero D, Eguchi A, Li H, Johnson CD, Papouchado BG, Wree A et al (2014) Quantification and size-profiling of extracellular vesicles using tunable resistive pulse sensing. J Vis Exp 92:e51623Google Scholar
- Cote GA, Gore AJ, McElyea SD, Heathers LE, Xu H, Sherman S et al (2014) A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile. Am J Gastroenterol 109:1942–1952PubMed CentralPubMedView ArticleGoogle Scholar
- Sheinerman KS, Umansky SR (2013) Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies. Front Cell Neurosci 7:150PubMed CentralPubMedView ArticleGoogle Scholar
- Jia S, Zocco D, Samuels ML, Chou MF, Chammas R, Skog J et al (2014) Emerging technologies in extracellular vesicle-based molecular diagnostics. Exp Rev Mol Diagn 14:307–321View ArticleGoogle Scholar
- Momen-Heravi F, Balaj L, Alian S, Trachtenberg AJ, Hochberg FH, Skog J et al (2012) Impact of biofluid viscosity on size and sedimentation efficiency of the isolated microvesicles. Front Physiol 3:162PubMed CentralPubMedGoogle Scholar
- Momen-Heravi F, Bala S, Bukong T, Szabo G (2014) Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages. Nanomedicine 10:1517–1527PubMedView ArticleGoogle Scholar
- Cheng L, Sharples RA, Scicluna BJ, Hill AF (2014) Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles 3:10PubMed CentralView ArticleGoogle Scholar
- Povero D, Eguchi A, Li H, Johnson CD, Papouchado BG, Wree A et al (2014) Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease. PLoS One 9:e113651PubMed CentralPubMedView ArticleGoogle Scholar
- Arrese M, Eguchi A, Feldstein AE (2015) Circulating microRNAs: emerging biomarkers of liver disease. Semin Liver Dis 35:43–54PubMedView ArticleGoogle Scholar
- O’Shea RS, Dasarathy S, McCullough AJ, Practice Guideline Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology (2010) Alcoholic liver disease. Hepatology 51:307–328PubMedView ArticleGoogle Scholar
- Petrasek J, Iracheta-Vellve A, Saha B, Satishchandran A, Kodys K, Fitzgerald KA et al (2015) Metabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease. J Leukoc Biol 98:249–256PubMedView ArticleGoogle Scholar
- Andersen CL, Jensen JL, Ørntoft TF (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64:5245–5250PubMedView ArticleGoogle Scholar
- Nath B, Levin I, Csak T, Petrasek J, Mueller C, Kodys K et al (2011) Hepatocyte-specific hypoxia-inducible factor-1α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice. Hepatology 53:1526–1537PubMed CentralPubMedView ArticleGoogle Scholar
- Momen-Heravi F, Balaj L, Alian S, Tigges J, Toxavidis V, Ericsson M et al (2012) Alternative methods for characterization of extracellular vesicles. Front Physiol 3:354PubMed CentralPubMedGoogle Scholar
- Leung TM, Lu Y, Yan W, Morón-Concepción JA, Ward SC, Ge X et al (2012) Argininosuccinate synthase conditions the response to acute and chronic ethanol-induced liver injury in mice. Hepatology 55:1596–1609PubMedView ArticleGoogle Scholar
- Momen Heravi F, Bala S, Kodys K, Szabo G (2015) Exosomes derived from alcohol-treated hepatocytes horizontally transfer liver specific miRNA-122 and sensitize monocytes to LPS. Sci Rep 5:9991PubMedView ArticleGoogle Scholar
- Momen-Heravi F, Balaj L, Alian S, Mantel PY, Halleck AE, Trachtenberg AJ et al (2013) Current methods for the isolation of extracellular vesicles. Biol Chem 394:1253–1262PubMedView ArticleGoogle Scholar
- Bukong TN, Momen-Heravi F, Kodys K, Bala S, Szabo G (2014) Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90. PLoS Pathog 10:e1004424PubMed CentralPubMedView ArticleGoogle Scholar
- Masyuk AI, Masyuk TV, Larusso NF (2013) Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases. J Hepatol 59:621–625PubMedView ArticleGoogle Scholar
- Rodríguez-Suárez E, Gonzalez E, Hughes C, Conde-Vancells J, Rudella A, Royo F et al (2014) Quantitative proteomic analysis of hepatocyte-secreted extracellular vesicles reveals candidate markers for liver toxicity. J Proteom 103:227–240View ArticleGoogle Scholar
- Raposo G, Stoorvogel W (2013) Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200:373–383PubMed CentralPubMedView ArticleGoogle Scholar
- Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F et al (2008) Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319:1244–1247PubMedView ArticleGoogle Scholar
- Théry C, Boussac M, Véron P, Ricciardi-Castagnoli P, Raposo G, Garin J et al (2001) Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 166:7309–7318PubMedView ArticleGoogle Scholar
- Akers JC, Ramakrishnan V, Kim R, Skog J, Nakano I, Pingle S et al (2013) miR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development. PLoS One 8:e78115PubMed CentralPubMedView ArticleGoogle Scholar
- Fujita Y, Kuwano K, Ochiya T, Takeshita F (2014) The impact of extracellular vesicle-encapsulated circulating microRNAs in lung cancer research. Biomed Res Int 2014:486413PubMed CentralPubMedView ArticleGoogle Scholar
- Turchinovich A, Weiz L, Langheinz A, Burwinkel B (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res 39:7223–7233PubMed CentralPubMedView ArticleGoogle Scholar
- Mathivanan S, Ji H, Simpson RJ (2010) Exosomes: extracellular organelles important in intercellular communication. J Proteom 73:1907–1920View ArticleGoogle Scholar
- Boukouris S, Mathivanan S (2015) Exosomes in bodily fluids are a highly stable resource of disease biomarkers. Proteom Clin Appl 9:358–367View ArticleGoogle Scholar
- Caradec J, Kharmate G, Hosseini-Beheshti E, Adomat H, Gleave M, Guns E (2014) Reproducibility and efficiency of serum-derived exosome extraction methods. Clin Biochem 47:1286–1292PubMedView ArticleGoogle Scholar
- Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q et al (2011) Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19:232–243PubMedView ArticleGoogle Scholar
- Bala S, Petrasek J, Mundkur S, Catalano D, Levin I, Ward J et al (2012) Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 56:1946–1957PubMed CentralPubMedView ArticleGoogle Scholar
- Postigo AA, Depp JL, Taylor JJ, Kroll KL (2003) Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins. EMBO J 22:2453–2462PubMed CentralPubMedView ArticleGoogle Scholar
- Klein S, Rick J, Schierwagen R, Uschner FE, Strassburg CP, Laleman W et al (2014) Jak2/Arhgef1 signaling correlates with severity of liver disease and represents a target for therapy of portal hypertension. Hepatology 60(S1):302A–304AGoogle Scholar
- Small EM, Frost RJ, Olson EN (2010) MicroRNAs add a new dimension to cardiovascular disease. Circulation 121:1022–1032PubMed CentralPubMedView ArticleGoogle Scholar
- Piano MR (2002) Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology. Chest 121:1638–1650PubMedView ArticleGoogle Scholar
- Alexander J, Mishra P, Desai N, Ambadekar S, Gala B, Sawant P (2007) Cirrhotic cardiomyopathy: Indian scenario. J Gastroenterol Hepatol 22:395–399PubMedView ArticleGoogle Scholar